Seagen Inc

ISIN US81181C1045 Symbol SGEN Industry Biotechnology Sector Healthcare
Seagen Price
153.4USD 1.36%
1y Low: 109.4
1y High: 213.9
1y Low: 109.4
1y High: 213.9
Seagen Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
seagen.com
Market Cap
25.2 B USD
Dividend Yield
Performance 1y
3.22 %
PER
41.3

Seagen Stock Chart

Seagen Dividend Chart

Seagen Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Seagen Performance

1 Week
3.28 %
1 Month
3.58 %
6 Months
22.55 %
Year to Date
8.99 %
1 Year
3.22 %
5 Years
307.3 %

Seagen Revenue, EBIT, and Income

Seagen Margins

Seagen Shares Outstanding

Useful Links

Search Twitter: $SGEN, #SGEN

Seagen Company Info

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; and PADCEV, an ADC composed of an anti-Nectin-4 monoclonal antibody for the treatment of metastatic urothelial cancers. It also develops Tucatinib, an investigational oral, small molecule TKI for HER2, a growth factor receptor; and Tisotumab Vedotin, an ADC composed of a human antibody that binds to tissue factor to treat various solid tumors, including cervical, ovarian, prostate, and bladder. In addition, the company develops ladiratuzumab vedotin, an ADC targeting LIV-1 and metastatic triple-negative breast cancer; SEA-BCMA, a clinical-stage non-fucosylated BCMA-directed antibody for patients with relapsed or refractory multiple myeloma. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; biotechnology and pharmaceutical companies; and Merck. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Seagen Price to Earnings Ratio (PE Ratio): 41.3

The current Price to Earnings Ratio of Seagen is 41.3.
The PE Ratio is calcluated by dividing the current Seagen share price (153.4 USD) by the earnings per share (3.4).

Seagen Market Cap: 25.2 B USD

The current market cap of Seagen is 25.2 B USD.

Seagen Stock Price: 153.4 USD

The current stock price of Seagen is 153.4 USD.

Seagen ISIN: US81181C1045

The ISIN (International Securities Identification Number) of Seagen is US81181C1045.

Seagen Ticker Symbol: SGEN

The ticker symbol of Seagen is SGEN.

Seagen Address

The address of the Seagen HQ is Building 3, 98021 Bothell, WA, USA.